Brief: Tevogen Bio Signs LOI With Cd8 Technology To Build $50 Million R&D And Manufacturing Facility

Tevogen

29/10/2024 18:13

Oct 29 (Reuters) - Tevogen Bio Holdings Inc  TVGN.O :
    * TEVOGEN BIO SIGNS LETTER OF INTENT WITH CD8 TECHNOLOGY TO
BUILD
UP TO A $50 MILLION RESEARCH AND DEVELOPMENT AND MANUFACTURING
FACILITY; NO IMPACT ON SHAREHOLDER EQUITY

Further company coverage:  TVGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))